semaglutide approved by fda Approval vs Compounded Alternatives FDA accepts filing application for

:contentReference[oaicite:6] Common Step-Up Pattern The Wegovy prescribing information describes: Start at 0.25 mg once weekly for 4 weeks Increase in 4-week intervals until reaching a maintenance dose (commonly 2.4 mg weekly, with some people maintaining at 1.7 mg)

Qualifying for GLP-1 therapy when following keto Qualifying for GLP-1 prescriptions typically requires a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia

Most GLP-1 users are already D-deficient before starting therapy

Yabe, D

This makes it a compelling option for clinicians looking to script the most effective treatment plans for their patients